Literature DB >> 36045189

The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy - a systematic review of the literature.

George Bazoukis1,2, Jeremy Man Ho Hui3,4, Yan Hiu Athena Lee3,5, Oscar Hou In Chou3,4, Dimitrios Sfairopoulos6, Konstantinos Vlachos7, Athanasios Saplaouras7, Konstantinos P Letsas7, Michael Efremidis7, Gary Tse8,9, Vassilios S Vassiliou10, Panagiotis Korantzopoulos6.   

Abstract

Despite the strict indications for cardiac resynchronization therapy (CRT) implantation, a significant proportion of patients will fail to adequately respond to the treatment. This systematic review aims to present the existing evidence about the role of cardiac magnetic resonance (CMR) in identifying patients who are likely to respond better to the CRT. A systematic search in the MedLine database and Cochrane Library from their inception to August 2021 was performed, without any limitations, by two independent investigators. We considered eligible observational studies or randomized clinical trials (RCTs) that enrolled patients > 18 years old with heart failure (HF) of ischaemic or non-ischaemic aetiology and provided data about the association of baseline CMR variables with clinical or echocardiographic response to CRT for at least 3 months. This systematic review was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA Statement). Following our search strategy, 47 studies were finally included in our review. CMR appears to have an additive role in identifying the subgroup of patients who will respond better to CRT. Specifically, the presence and the extent of myocardial scar were associated with increased non-response rates, while those with no scar respond better. Furthermore, existing data show that scar location can be associated with CRT response rates. CMR-derived markers of mechanical desynchrony can also be used as predictors of CRT response. CMR data can be used to optimize the position of the left ventricular lead during the CRT implantation procedure. Specifically, positioning the left ventricular lead in a branch of the coronary sinus that feeds an area with transmural scar was associated with poorer response to CRT. CMR can be used as a non-invasive optimization tool to identify patients who are more likely to achieve better clinical and echocardiographic response following CRT implantation.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CRT response; Cardiac magnetic resonance; Cardiac resynchronization therapy; Late gadolinium enhancement; Myocardial fibrosis

Mesh:

Year:  2022        PMID: 36045189     DOI: 10.1007/s10741-022-10263-5

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.654


  110 in total

1.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

2.  Agreement is poor among current criteria used to define response to cardiac resynchronization therapy.

Authors:  Brandon K Fornwalt; William W Sprague; Patrick BeDell; Jonathan D Suever; Bart Gerritse; John D Merlino; Derek A Fyfe; Angel R León; John N Oshinski
Journal:  Circulation       Date:  2010-04-26       Impact factor: 29.690

3.  Effects of global longitudinal strain and total scar burden on response to cardiac resynchronization therapy in patients with ischaemic dilated cardiomyopathy.

Authors:  Antonello D'Andrea; Pio Caso; Raffaella Scarafile; Lucia Riegler; Gemma Salerno; Francesca Castaldo; Rita Gravino; Rosangela Cocchia; Luca Del Viscovo; Giuseppe Limongelli; Giovanni Di Salvo; Luigi Ascione; Raffaele Iengo; Sergio Cuomo; Lucio Santangelo; Raffaele Calabrò
Journal:  Eur J Heart Fail       Date:  2009-01       Impact factor: 15.534

4.  CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy.

Authors:  Tomas G Neilan; Otavio R Coelho-Filho; Stephan B Danik; Ravi V Shah; John A Dodson; Daniel J Verdini; Michifumi Tokuda; Caroline A Daly; Usha B Tedrow; William G Stevenson; Michael Jerosch-Herold; Brian B Ghoshhajra; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2013-08-08

Review 5.  Cardiovascular magnetic resonance imaging in heart failure.

Authors:  Kihei Yoneyama; Yuki Kitanaka; Osamu Tanaka; Yoshihiro J Akashi
Journal:  Expert Rev Cardiovasc Ther       Date:  2018-02-27

6.  Midwall Fibrosis and 5-Year Outcome in Moderate and Severe Aortic Stenosis.

Authors:  Vassilios S Vassiliou; Aris Perperoglou; Claire E Raphael; Sanjiv Joshi; Tamir Malley; Russell Everett; Brian Halliday; Dudley J Pennell; Marc R Dweck; Sanjay K Prasad
Journal:  J Am Coll Cardiol       Date:  2017-04-04       Impact factor: 24.094

7.  Identification of myocardial diffuse fibrosis by 11 heartbeat MOLLI T 1 mapping: averaging to improve precision and correlation with collagen volume fraction.

Authors:  Vassilios S Vassiliou; Katharina Wassilew; Donnie Cameron; Ee Ling Heng; Evangelia Nyktari; George Asimakopoulos; Anthony de Souza; Shivraman Giri; Iain Pierce; Andrew Jabbour; David Firmin; Michael Frenneaux; Peter Gatehouse; Dudley J Pennell; Sanjay K Prasad
Journal:  MAGMA       Date:  2017-06-12       Impact factor: 2.310

8.  Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement.

Authors:  Brian P Halliday; A John Baksi; Ankur Gulati; Aamir Ali; Simon Newsome; Cemil Izgi; Monika Arzanauskaite; Amrit Lota; Upasana Tayal; Vassilios S Vassiliou; John Gregson; Francisco Alpendurada; Michael P Frenneaux; Stuart A Cook; John G F Cleland; Dudley J Pennell; Sanjay K Prasad
Journal:  JACC Cardiovasc Imaging       Date:  2018-09-12

9.  A novel cardiovascular magnetic resonance risk score for predicting mortality following surgical aortic valve replacement.

Authors:  Vassilios S Vassiliou; Menelaos Pavlou; Tamir Malley; Brian P Halliday; Vasiliki Tsampasian; Claire E Raphael; Gary Tse; Miguel Silva Vieira; Dominique Auger; Russell Everett; Calvin Chin; Francisco Alpendurada; John Pepper; Dudley J Pennell; David E Newby; Andrew Jabbour; Marc R Dweck; Sanjay K Prasad
Journal:  Sci Rep       Date:  2021-10-12       Impact factor: 4.379

10.  Clinical effectiveness of a dedicated cardiac resynchronization therapy pre-assessment clinic incorporating cardiac magnetic resonance imaging and cardiopulmonary exercise testing on patient selection and outcomes.

Authors:  Baldeep S Sidhu; Justin Gould; Mark K Elliott; Vishal S Mehta; Steven A Niederer; Gerald Carr-White; Christopher A Rinaldi
Journal:  Int J Cardiol Heart Vasc       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.